Results 81 to 90 of about 8,128 (220)
Uses of Botulinum Toxin in Headache and Facial Pain Disorders: An Update
Botulinum toxin is a neurotoxin that is used in the treatments for several medical conditions, such as dystonia, spasticity, hemifacial spasm, overactive bladder, and hyperhidrosis.
Pedro Augusto Sampaio Rocha-Filho +3 more
doaj +1 more source
Abstract Background Functional movement disorder (FMD), a subtype of functional neurological disorder, is a complex neuropsychiatric syndrome characterized by inconsistent and incongruent motor symptoms. Despite its relatively high prevalence, FMD remains associated with delayed diagnosis, significant disability, and limited evidence to guide ...
Andrea Soumbasis +6 more
wiley +1 more source
Missense Variants in the A Isoform of FGF13 as a Novel Cause of Paroxysmal Dyskinesia
Abstract Background Pathogenic variants within the unique N‐terminal inactivation particle of FGF13 isoform A (FGF13A) have so far been associated only with an X‐linked dominant epileptic encephalopathy (DEE). Objective The aim was to expand the clinical and molecular spectrum of FGF13A‐related disorder.
Cyril Mignot +22 more
wiley +1 more source
Sensorimotor overactivity as a pathophysiologic trait of embouchure dystonia.
BACKGROUND: Embouchure dystonia is a focal task-specific dystonia affecting the complex interplay of lower facial, jaw, and tongue muscles in musicians playing brass or woodwind instruments.
Haslinger, B;Altenmuller, E;Castrop, F;Zimmer, C;Dresel, C
core +1 more source
Facial Aberrant Reinnervation Syndrome (FARS) Causing Synkinetic Dystonia of Platysma [PDF]
Facial Aberrant Reinnervation Syndrome (FARS) is a sequela of facial nerve injury. The clinical presentations are varied in form of facial synkinesis, facial muscle hypertonicity, and facial muscle spasm/twitching, which occur following facial nerve ...
Sourya Acharya, Amol Andhale
doaj +1 more source
Movement Disorders Clinical Practice, EarlyView.
Luca Angelini, Rick C.G. Helmich
wiley +1 more source
Abstract Background Spastic paresis, resulting from central nervous system lesions, significantly impairs functional performance. In the framework of the International Classification of Functioning, Disability, and Health, functional performance was defined as functioning at the activity level in relation to the impairment of body functions and ...
Martina Hoskovcova +13 more
wiley +1 more source
Phenotypic Clues in Infantile‐Onset Parkinsonism‐Dystonia‐2: A Treatable Neurotransmitter Disorder
Movement Disorders Clinical Practice, EarlyView.
Sangeetha Yoganathan +10 more
wiley +1 more source
Abstract Background SRRM4 is an exclusively neural‐expressed splicing‐factor gene not yet associated with a monogenic condition. Objective We sought to delineate movement disorders caused by SRRM4 variants. De novo splice‐donor‐site variants at position +2 of intron 5 of SRRM4 (c.464+2T>C, c.464+2T>A) occurred in three unrelated patients with dystonia ...
Philip Harrer +24 more
wiley +1 more source
Levodopa-Induced Jaw and Facial Dystonia in a Case of Progressive Supranuclear Palsy with Blepharospasm. [PDF]
Onder H, Comoglu S.
europepmc +1 more source

